ABP — ABPRO Holdings Income Statement
0.000.00%
Last trade - 00:00HealthcareBalancedMicro Cap
- $3.56m
- $3.56m
- $2.20m
Annual income statement for ABPRO Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0.48 | 2.03 | 0.122 | 0.183 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 15.2 | 18.7 | 11.9 | 9.93 |
| Operating Profit | -14.7 | -16.7 | -11.7 | -9.75 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -14.7 | -16.9 | -11.7 | -7.23 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -14.7 | -17.2 | -11.7 | -7.23 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -14.7 | -17.2 | -11.7 | -7.23 |
| Adjustments to Net Income | ||||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -14.7 | -17.2 | -11.7 | -17.4 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.297 | -0.341 | -0.232 | -0.751 |